Timeline
Ridgeback Biotherapeutics
Florida biotech that developed Ebanga, the Zaire ebolavirus monoclonal with no approved Bundibugyo efficacy.
2 of 2 entries (2 events, 0 interactions)
Filters
#7 12 Jun
Mentioned in: First Ebola treatment trial goes live
Pandemics and Biosecurity#3 17 May